A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
If necessary, you may be referred to another specialist within the NHS, such as a haematologist, gastroenterologist, or dietician
This can lead to an increase in joint degeneration, particularly in weight-bearing joints like the knees, hips, and lower back
The loading phase is extended, with injections given on alternate days until no further improvement is observed, which may take several weeks or months
Retrieved May 6, 2025, from SkinKraft
The highest incidence occurs between the ages of 30 and 60